4Schilp J, de Blok C, Langelaan M, et al. Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy[J]. BMC Nephrol, 2(}14, 15 (1): 2.
5Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention ofradiographic-contrast-agent-induced reductions in renal func- tion by acetylcysteine[J]. N Engl J Med, 2000, 343(3) : 180- 184.
6Zhang B, Liang L, Chen W, et al. The efficacy of sodium bi- carbonate in preventing contrast-induced nephropathy in pa- tients with pre-existing renal insufficiency: a meta-analysis [J].BMJ Open, 2015, 5(3): e6989.
7Chong E, Poh KK, Liang S, et al. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine[J]. Ann Acad Med Singapore, 2010, 39(5): 374-380.
8Heyman SN, Rosen S, Khamaisi M, et al. Reactive oxygen species and the pathogenesis of radiocontrast-induced nephrop- athy[J]. Invest Radiol, 2010, 45(4) : 188-195.
9Olsson B, Johansson M, Gabrielsson J, et al. Pharmacokinet- ics and bioavailability of reduced and oxidized N-acetylcysteine [J]. Eur J Clin Pharmacol, 1988, 34(1) : 77-82.
10Gibson PG, Simpson JL . The overlap syndrome of asthma and COPD : what are its features and how important is it [ J ]. orax, 2009,64:728 - 735.
